| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Aggressive characteristics of myeloblasts expressing CD7 in myelodysplastic syndromes
|
Satoh, Chikako
|
|
2009
|
33 |
2 |
p. 326-331
6 p.
|
artikel
|
| 2 |
A pilot dose-escalating study of alemtuzumab plus cyclosporine for patients with bone marrow failure syndrome
|
Kim, Hawk
|
|
2009
|
33 |
2 |
p. 222-231
10 p.
|
artikel
|
| 3 |
Calorimetric study as a potential test for choosing treatment of B-cell chronic lymphocytic leukemia
|
Rogalinska, Malgorzata
|
|
2009
|
33 |
2 |
p. 308-314
7 p.
|
artikel
|
| 4 |
CD38 as a prognostic factor in Chinese patients with chronic lymphocytic leukaemia
|
Xu, Wei
|
|
2009
|
33 |
2 |
p. 237-243
7 p.
|
artikel
|
| 5 |
Circulating heat shock protein 70 and progression in patients with chronic myeloid leukemia
|
Yeh, Chen-Hsiung
|
|
2009
|
33 |
2 |
p. 212-217
6 p.
|
artikel
|
| 6 |
Cytogenetic and molecular responses to standard-dose imatinib in chronic myeloid leukemia are correlated with Sokal risk scores and duration of therapy but not trough imatinib plasma levels
|
Forrest, Donna L.
|
|
2009
|
33 |
2 |
p. 271-275
5 p.
|
artikel
|
| 7 |
Differential in vitro cytotoxicity does not explain increased host toxicities from chemotherapy in Down syndrome acute lymphoblastic leukemia
|
Valle, Mariela
|
|
2009
|
33 |
2 |
p. 336-339
4 p.
|
artikel
|
| 8 |
Do peripheral blasts count in myelodysplastic syndromes?
|
Alhan, Canan
|
|
2009
|
33 |
2 |
p. 209-211
3 p.
|
artikel
|
| 9 |
Editorial Board
|
|
|
2009
|
33 |
2 |
p. CO2-
1 p.
|
artikel
|
| 10 |
Extracellular heat shock protein 70: A potential prognostic marker for chronic myeloid leukemia
|
Nylandsted, Jesper
|
|
2009
|
33 |
2 |
p. 205-206
2 p.
|
artikel
|
| 11 |
Genetic aberrations including chromosome 1 abnormalities and clinical features of plasma cell leukemia
|
Chang, Hong
|
|
2009
|
33 |
2 |
p. 259-262
4 p.
|
artikel
|
| 12 |
HDAC inhibitors in leukemia: Current status and perspectives
|
Kouraklis, Gregory
|
|
2009
|
33 |
2 |
p. 207-208
2 p.
|
artikel
|
| 13 |
Levels of beta 2 microglobulin have a prognostic relevance for patients with myelodysplastic syndrome with regard to survival and the risk of transformation into acute myelogenous leukemia
|
Neumann, Frank
|
|
2009
|
33 |
2 |
p. 232-236
5 p.
|
artikel
|
| 14 |
Ligand-induced Flt3-downregulation modulates cell death associated proteins and enhances chemosensitivity to idarubicin in THP-1 acute myeloid leukemia cells
|
Oveland, Eystein
|
|
2009
|
33 |
2 |
p. 276-287
12 p.
|
artikel
|
| 15 |
Oxidative DNA damage in bone marrow cells of patients with low-risk myelodysplastic syndrome
|
Novotna, Bozena
|
|
2009
|
33 |
2 |
p. 340-343
4 p.
|
artikel
|
| 16 |
Paternal smoking, genetic polymorphisms in CYP1A1 and childhood leukemia risk
|
Lee, Kyoung-Mu
|
|
2009
|
33 |
2 |
p. 250-258
9 p.
|
artikel
|
| 17 |
PI3K/Akt inhibition modulates multidrug resistance and activates NF-κB in murine lymphoma cell lines
|
García, Mariana G.
|
|
2009
|
33 |
2 |
p. 288-296
9 p.
|
artikel
|
| 18 |
Polymorphisms and haplotypes in the multidrug resistance 1 gene (MDR1/ABCB1) and risk of multiple myeloma
|
Jamroziak, Krzysztof
|
|
2009
|
33 |
2 |
p. 332-335
4 p.
|
artikel
|
| 19 |
Receptor mutation is not a common mechanism of naturally occurring glucocorticoid resistance in leukaemia cell lines
|
Beesley, Alex H.
|
|
2009
|
33 |
2 |
p. 321-325
5 p.
|
artikel
|
| 20 |
Renal failure and recovery associated with second-generation Bcr-Abl kinase inhibitors in imatinib-resistant chronic myelogenous leukemia
|
Holstein, Sarah A.
|
|
2009
|
33 |
2 |
p. 344-347
4 p.
|
artikel
|
| 21 |
Results of a phase I/II British Society of Bone Marrow Transplantation study on PCR-based pre-emptive therapy with valganciclovir or ganciclovir for active CMV infection following alemtuzumab-based reduced intensity allogeneic stem cell transplantation
|
Lim, Z.Y.
|
|
2009
|
33 |
2 |
p. 244-249
6 p.
|
artikel
|
| 22 |
Sodium butyrate enhances the cytotoxic effect of antineoplastic drugs in human lymphoblastic T-cells
|
dos Santos, M.P.
|
|
2009
|
33 |
2 |
p. 218-221
4 p.
|
artikel
|
| 23 |
Sorafenib (Nexavar®) induces molecular remission and regression of extramedullary disease in a patient with FLT3-ITD+ acute myeloid leukemia
|
Safaian, N.N.
|
|
2009
|
33 |
2 |
p. 348-350
3 p.
|
artikel
|
| 24 |
Tannic acid-induced apoptosis and -enhanced sensitivity to arsenic trioxide in human leukemia HL-60 cells
|
Chen, Kuo-Shuen
|
|
2009
|
33 |
2 |
p. 297-307
11 p.
|
artikel
|
| 25 |
The physician–patient relationship and quality of life: Lessons from chronic lymphocytic leukemia
|
Shanafelt, Tait D.
|
|
2009
|
33 |
2 |
p. 263-270
8 p.
|
artikel
|
| 26 |
Transferrin induces interleukin-18 expression in chronic myeloid leukemia cell line, K-562
|
Park, Sunyoung
|
|
2009
|
33 |
2 |
p. 315-320
6 p.
|
artikel
|
Tijdschrift beschrijving